APOA1 and atherosclerosis: Furthermore, the human recombinant APOA-I Milano variant (which contains the R173C mutation and confers protection against atherosclerosis development) also decreased RAGE levels in cortical vessels and modified insoluble brain Aβ burden in APP23 transgenic mice [134].